82885-73-2 Usage
Uses
Used in Skincare Products:
Ferulic acid is used as an active ingredient in skincare products for its antioxidant and anti-inflammatory properties. It helps protect the skin from environmental stressors and promotes a healthy, youthful appearance.
Used in Dietary Supplements:
As a dietary supplement, ferulic acid is used for its potential health benefits, which include cardiovascular protection, cancer prevention, and neuroprotection. It supports overall health and well-being.
Used in Pharmaceutical Formulations:
Ferulic acid is used as a stabilizing and efficacy-enhancing component in pharmaceutical formulations. It has been studied for its ability to enhance the stability and efficacy of other antioxidants, such as vitamins C and E, making it a valuable addition to various medicinal products.
Used in the Food Industry:
In the food industry, ferulic acid is used as a natural preservative and flavor enhancer due to its antioxidant properties. It helps extend the shelf life of products and improve their taste and aroma.
Used in Cosmetic Formulations:
Ferulic acid is used in cosmetic formulations for its antioxidant and anti-inflammatory properties. It helps protect the skin from environmental stressors, reduces the appearance of fine lines and wrinkles, and promotes a more radiant and youthful complexion.
Check Digit Verification of cas no
The CAS Registry Mumber 82885-73-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,8,8 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 82885-73:
(7*8)+(6*2)+(5*8)+(4*8)+(3*5)+(2*7)+(1*3)=172
172 % 10 = 2
So 82885-73-2 is a valid CAS Registry Number.
InChI:InChI=1/C20H18O4/c1-14(12-20(22)23)17-13-16(9-11-19(17)24-2)18(21)10-8-15-6-4-3-5-7-15/h3-13H,1-2H3,(H,22,23)/b10-8+,14-12+
82885-73-2Relevant academic research and scientific papers
New cinnamoyl-cinnamic acid derivative, and its use as pharmaceutical
-
, (2008/06/13)
The present invention relates to a new cinnamoyl-cinnamic acid derivative selected from the group constituted by: (i) the m-cinnamoyl-cinnamic acid derivatives of formula STR1 in which: Xo,X1,X2,X3,X4, which are identical or different, each represent an atom of hydrogen, a halogen, a lower alkyl group, a lower alkoxy group, the group NRR' (where R and R' identical or different, each represent an atom of hydrogen or a lower alkyl group), the group NO2, CF3 or OH; R1 represents an atom of hydrogen or a lower alkyl group; R2 represents an atom of hydrogen or the methyl group; Y represents a group OH, OR3 (where R3 is a lower alkyl group), NRR' (where R and R' are defined as hereinabove) or the group O(CH2)n NR4 R5 (where n is an integer of value 1 to 5--and preferably 2 or 3)--; and R4 and R5, identical or different, each represent an atom of hydrogen, a lower alkyl group and may form with the nitrogen atom to which they are bonded a heterocyclic group of 5 to 7 vertices capable of being substituted and of comprising one or more other heteroatoms such as N and O); (ii) their geometrical isomers; and (iii) their salts. It also relates to its method of preparation and its use as pharmaceutical.
